BioMarin Pharmaceutical (BMRN): Q3 EPS of -$0.04 beats by $0.16. Revenue of $128.1M (+13% Y/Y)...

|About: BioMarin Pharmaceutical ... (BMRN)|By:, SA News Editor
BioMarin Pharmaceutical (BMRN): Q3 EPS of -$0.04 beats by $0.16. Revenue of $128.1M (+13% Y/Y) in-line. (PR)